Market accessOfficial
Pharmaceutical expenditure January-April 2026: AIFA monitoring (AIFA)
🇮🇹 AIFA · Fri 06 Nov 2026
AIFA's monitoring of Italian public pharmaceutical expenditure for January-April 2026 shows total spend (convenzionata, direct purchases and oxygen) of €9,036.9 million, equal to 19.26% of the national health fund (FSN), based on the provisional 2026 FSN value communicated by the Ministry of Health. It is relevant mainly to market access and pricing/reimbursement teams tracking spending-ceiling pressure; it has no direct pharmacovigilance or quality implications.
Summary written by VigiEye from the official notice. AI-assisted; check the source before acting.
More Market access
All →
Market accessCompany releaseMedicare begins paying for Lucid's EsoGuard as PAVmed's Veris nears FDA 510(k) filing
🇺🇸 PAVmed Inc. (PAVM) · Fri 13 Nov 2026
Market accessOfficialDenmark updates Voltabak eye drop supply notice, with shortage expected to run to mid-May 2027
🇩🇰 DKMA · Fri 13 Nov 2026
Market accessOfficialMethergin 0.2 mg/ml injection withdrawn from Danish market, DKMA reports
🇩🇰 DKMA · Fri 13 Nov 2026
Market accessOfficialDenmark updates import window for estradiol 25 microgram patches in supply failure
🇩🇰 DKMA · Fri 13 Nov 2026
Market accessOfficialDKMA updates Vivelle Dot 37.5 supply notice: shortage expected to last until end of December
🇩🇰 DKMA · Fri 13 Nov 2026
Market accessOfficialIntersurgical breathing systems: connectors can detach from Smoothbore tube, IGJ posts safety notice
🇳🇱 IGJ · Thu 12 Nov 2026